Inhibitory effect of celecoxib in lung carcinoma by regulation of cyclooxygenase-2/cytosolic phospholipase A 2 and peroxisome proliferator-activated receptor gamma

Molecular and Cellular Biochemistry

Volumn 355, Issue 1-2, 2011, Pages 233-240

  Zhang, Ming ^a   Xu, Zhi Gang ^a   Shi, Zhuo ^a   Shao, Dan ^a   Li, Ou ^a   Li, Wei ^a,c   Li, Zhi Jun ^b   Wang, Kai Zhong ^b   Chen, Li ^a  

^a Basic Medical College   (China)

^b THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^c JILIN AGRICULTURAL UNIVERSITY   (China)

Author keywords

Arachidonic acid; Celecoxib; Cyclooxygenase 2; Peroxisome proliferator activated receptor gamma; Prostaglandin E 2

Indexed keywords

ARACHIDONIC ACID; CELECOXIB; CYCLOOXYGENASE 2; CYTOSOLIC PHOSPHOLIPASE A2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN E2;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEWIS CARCINOMA; MITOCHONDRIAL MEMBRANE POTENTIAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SUPERNATANT; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; ARACHIDONIC ACIDS; AREA UNDER CURVE; CARCINOMA, LEWIS LUNG; CELL LINE, TUMOR; CELL SURVIVAL; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DINOPROSTONE; PHOSPHOLIPASES A2, CYTOSOLIC; PPAR GAMMA; PYRAZOLES; SULFONAMIDES;

EID: 80051549466     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-0859-5     Document Type: Article

References (37)

1. M Matsuyama R Yoshimura 2009 Arachidonic acid pathway: a molecular target in human testicular cancer Mol Med Rep 2 527 531 1:CAS:528:DC%2BD1MXnvFGnu78%3D
2. M Matsuyama R Yoshimura 2008 The target of arachidonic acid pathway is a new anticancer strategy for human prostate cancer Biologics 2 725 732 19707453 1:CAS:528:DC%2BD1MXjvVyhtbw%3D
3. I Avis A Martinez J Tauler, et al. 2005 Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition Cancer Res 65 41 90 10.1158/0008-5472.CAN-04-3441 (Pubitemid 40775656)
4. T Wu 2006 Cyclooxygenase-2 in hepatocellular carcinoma Cancer Treat Rev 32 28 44 16337744 10.1016/j.ctrv.2005.10.004 1:CAS:528:DC%2BD28XhtFWgsrY%3D (Pubitemid 43159775)
5. K Yoshimatsu NK Altorki D Golijanin, et al. 2001 Inducible prostaglandin E synthase is overexpressed in non-small cell lung cancer Clin Cancer Res 7 2669 2674 11555578 1:CAS:528:DC%2BD3MXnsFSitrg%3D (Pubitemid 32911370)
6. T Hida Y Yatabe H Achiwa, et al. 1998 Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas Cancer Res 58 3761 3764 9731479 1:CAS:528:DyaK1cXlvVyrtbk%3D (Pubitemid 28405625)
7. RA Soslow AJ Dannenberg D Rush, et al. 2000 COX-2 is expressed in human pulmonary, colonic, and mammary tumors Cancer 89 2637 2645 11135226 10.1002/1097-0142(20001215)89:12<2637::AID-CNCR17>3.0.CO;2-B 1:CAS:528:DC%2BD3MXitFWisw%3D%3D (Pubitemid 32011609)
8. S Gupta M Srivastava N Ahmad, et al. 2000 Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma Prostate 42 73 78 10579801 10.1002/(SICI)1097-0045(20000101)42:1<73::AID-PROS9>3.0.CO;2-G 1:CAS:528:DC%2BD3cXisVCqtw%3D%3D (Pubitemid 30004877)
9. H Sano Y Kawahito RL Wilder, et al. 1995 Expression of cyclooxygenase-1 and -2 in human colorectal cancer Cancer Res 55 3785 3789 7641194 1:CAS:528:DyaK2MXnvVelsbg%3D
10. D Hwang D Scollard J Byrne, et al. 1998 Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer J Natl Cancer Inst 90 455 460 9521170 10.1093/jnci/90.6.455 1:STN:280:DyaK1c7otVCltw%3D%3D (Pubitemid 28160637)
11. E Fosslien 2000 Molecular pathology of cyclooxygenase-2 in neoplasia Ann Clin Lab Sci 30 3 21 10678579 1:CAS:528:DC%2BD3cXht1altr8%3D (Pubitemid 30078300)
12. X Tang YJ Sun E Half, et al. 2002 Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human colon cancer cells Cancer Res 62 4903 4908 12208739 1:CAS:528:DC%2BD38Xmslylurc%3D (Pubitemid 34984412)
13. UC Nzeako ME Guicciardi JH Yoon, et al. 2002 COX-2 inhibits Fas-mediated apoptosis in cholangiocarcinoma cells Hepatology 35 552 559 11870367 10.1053/jhep.2002.31774 1:CAS:528:DC%2BD38Xitlyqsb8%3D (Pubitemid 34183958)
14. WS Chen SJ Wei JM Liu, et al. 2001 Tumor invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase-2 (COX-2) expression and inhibited by a COX-2-selective inhibitor, etodolac Int J Cancer 91 894 899 11275997 10.1002/1097-0215(200102)9999:9999<894::AID-IJC1146>3. 0.CO;2-# 1:CAS:528:DC%2BD3MXhsFGjt70%3D (Pubitemid 32178662)
15. S Tomozawa NH Tsuno E Sunami, et al. 2000 Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer Br J Cancer 83 324 328 10917546 10.1054/bjoc.2000.1270 1:CAS:528:DC%2BD3cXlslens74%3D (Pubitemid 30453571)
16. KM Leahy AT Koki JL Masferrer 2000 Role of cyclooxygenases in angiogenesis Curr Med Chem 7 1163 1170 11032965 1:CAS:528:DC%2BD3cXotFWrsrk%3D
17. M Nakanishi DW Rosenberg 2006 Roles of cPLA2alpha and arachidonic acid in cancer Biochim Biophys Acta 1761 1335 1343 17052951 1:CAS:528: DC%2BD28Xht1CisLjM (Pubitemid 44738711)
18. B Li L Gu H Zhang J Huang, et al. 2007 Up-regulation of cPLA(2) gene expression in astrocytes by all three conventional anti-bipolar drugs is drug-specific and enzyme-specific Psychopharmacology (Berl) 194 333 345 10.1007/s00213-007-0853-5 1:CAS:528:DC%2BD2sXhtVWqu73N (Pubitemid 47389352)
19. P Sertznig M Seifert W Tilgen, et al. 2007 Present concepts and future outlook: function of peroxisome proliferator-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer J Cell Physiol 212 1 12 17443682 10.1002/jcp.20998 1:CAS:528:DC%2BD2sXmtVWksbY%3D (Pubitemid 46876399)
20. VG Keshamouni S Han J Roman 2007 Peroxisome proliferator-activated receptors in lung cancer PPAR Res 2007 90289 18274632
21. T Wang J Xu X Yu, et al. 2006 Peroxisome proliferator-activated receptor gamma in malignant diseases Crit Rev Oncol Hematol 58 1 14 16388966 10.1016/j.critrevonc.2005.08.011
22. S Han J Roman 2007 Peroxisome proliferator-activated receptor gamma: a novel target for cancer therapeutics? Anticancer Drugs 18 237 244 17264754 10.1097/CAD.0b013e328011e67d 1:CAS:528:DC%2BD2sXhtVGis7c%3D (Pubitemid 46192975)
23. L Tian J Zhou MC Casimiro, et al. 2009 Activating peroxisome proliferator-activated receptor gamma mutant promotes tumor growth in vivo by enhancing angiogenesis Cancer Res 69 9236 9244 19934321 10.1158/0008-5472.CAN- 09-2067 1:CAS:528:DC%2BD1MXhsFGrtbvF
24. NP Evans SA Misyak EM Schmelz, et al. 2010 Conjugated linoleic acid ameliorates inflammation-induced colorectal cancer in mice through activation of PPARgamma J Nutr 140 515 521 20089779 10.3945/jn.109.115642 1:CAS:528:DC%2BC3cXnsFKhsbY%3D
25. JL Masferrer KM Leahy AT Koki, et al. 2000 Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors Cancer Res 60 1306 1311 10728691 1:CAS:528:DC%2BD3cXhvFWrt74%3D (Pubitemid 30151999)
26. RD Blumenthal C Waskewich DM Goldenberg, et al. 2001 Chronotherapy and chronotoxicity of the cyclooxygenase-2 inhibitor, celecoxib, in athymic mice bearing human breast cancer xenografts Clin Cancer Res 7 3178 3185 11595712 1:CAS:528:DC%2BD3MXnvF2rsrs%3D (Pubitemid 32963841)
27. CS Williams AJ Watson H Sheng, et al. 2000 Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models Cancer Res 60 6045 6051 11085526 1:CAS:528: DC%2BD3cXotV2lsLw%3D
28. XH Liu 2000 Inhibition of cyclooxgenase-2 suppresses angiogenesis and the growth of prostate cancer invivo J Urol 164 820 825 10953162 10.1016/S0022-5347(05)67321-1 1:CAS:528:DC%2BD3cXmtlSmtr8%3D (Pubitemid 30637640)
29. C Waskewich RD Blumenthal H Li, et al. 2002 Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines Cancer Res 62 2029 2033 11929821 1:CAS:528:DC%2BD38XivVylurw%3D (Pubitemid 34408448)
30. SA Blaine M Wick C Dessev, et al. 2001 Induction of cPLA2 in lung epithelial cells and non-small cell lung cancer is mediated by Sp1 and c-Jun J Biol Chem 276 42737 44243 11559711 10.1074/jbc.M107773200 1:CAS:528: DC%2BD3MXptlemu70%3D
31. MS Shaik A Chatterjee T Jackson, et al. 2006 Enhancement of antitumor activity of docetaxel by celecoxib in lung tumors Int J Cancer 118 396 404 16052515 10.1002/ijc.21325 1:CAS:528:DC%2BD2MXhtlWqsL7L (Pubitemid 41779079)
32. L Scorrano D Penzo V Petronilli, et al. 2001 Arachidonic acid causes cell death through the mitochondrial permeability transition. Implications for tumor necrosis factor-alpha apoptotic signaling J Biol Chem 276 12035 12040 11134037 10.1074/jbc.M010603200 1:CAS:528:DC%2BD3MXjtFylt74%3D
33. S Theocharis H Kanelli E Politi, et al. 2002 Expression of peroxisome proliferator activated receptor-gamma in non-small cell lung carcinoma: correlation with histological type and grade Lung Cancer 36 249 255 12009233 10.1016/S0169-5002(02)00013-2 (Pubitemid 34497122)
34. S Han J Roman 2006 Rosiglitazone suppresses human lung carcinoma cell growth through PPARgamma-dependent and PPARgamma-independent signal pathways Mol Cancer Ther 5 430 437 16505118 10.1158/1535-7163.MCT-05-0347 1:CAS:528:DC%2BD28XhvVelsbw%3D
35. S Hazra RK Batra HH Tai, et al. 2007 Pioglitazone and rosiglitazone decrease prostaglandin E2 in non-small-cell lung cancer cells by up-regulating 15-hydroxyprostaglandin dehydrogenase Mol Pharmacol 71 1715 1720 17412838 10.1124/mol.106.033357 1:CAS:528:DC%2BD2sXmt1Wqur8%3D (Pubitemid 47010924)
36. G Krey O Braissant F L'Horset, et al. 1997 Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay Mol Endocrinol 11 779 791 9171241 10.1210/me.11.6.779 1:CAS:528:DyaK2sXjsVSjsLw%3D (Pubitemid 27225305)
37. JM Lehmann JM Lenhard BB Oliver, et al. 1997 Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs J Biol Chem 272 3406 3410 9013583 10.1074/jbc.272.6.3406 1:CAS:528:DyaK2sXhtFeltLc%3D (Pubitemid 27066837)